Bluecross Idaho Prior Authorization Lookup
Latest Bluecross Idaho prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2027-01-01Biological Treatments for Refractory Myasthenia GravisThis policy governs medical necessity and prior authorization for specified biologic treatments used to treat generalized myasthenia gravis (gMG). Coverage applies to eligible individuals when the drug-specific clinical, laboratory, prior-treatment, safety, and response criteria are met.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2027-01-01Simponi Aria (golimumab) for Intravenous UseMedical-benefit coverage and prior authorization for intravenous golimumab for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. Subcutaneous golimumab is handled under the pharmacy benefit and is outside this policy.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-26Psychological TestingThis policy governs coverage and prior authorization requirements for formal psychological testing used to clarify psychiatric diagnoses or guide behavioral health treatment. It applies subject to the member-specific benefit plan, applicable law, and line-of-business provisions.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-01Entyvio (vedolizumab) for Inflammatory Bowel DiseaseThis policy governs medical necessity and prior authorization requirements for intravenous and subcutaneous Entyvio used to treat moderate-to-severely active ulcerative colitis or Crohn's disease. Subcutaneous Entyvio is processed under the pharmacy benefit and is subject to applicable formulary and utilization-management requirements.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-01Yartemlea (narsoplimab-wuug) for Hematopoietic Stem Cell Transplant-Associated Thrombotic MicroangiopathyThis policy governs medical-necessity and prior-authorization requirements for intravenous Yartemlea in adults and children at least 2 years old with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). It specifies diagnostic confirmation, documentation, specialist involvement, dosing, quantity limits, and continuation-response requirements.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01Evenity (romosozumab-aqqg) for Postmenopausal OsteoporosisMedical-benefit coverage and prior authorization for Evenity in postmenopausal females with osteoporosis who meet specified fracture-risk, prior-therapy, combination-use, duration, and dosing requirements. Pharmacy-benefit requests are outside this policy's scope.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-25Medically Necessary Pediatric Orthodontia Coverage GuidelinesCoverage and prior-authorization requirements for pediatric orthodontic services, generally for members under age 19, when craniofacial anomalies or traumatic injury cause functional impairment.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-01Gazyva (obinutuzumab) for Non-oncologic UsesDefines medical benefit coverage and prior authorization criteria for intravenous obinutuzumab when used for non-oncologic indications, primarily for treatment of active lupus nephritis in adults; applies to Bluecross Idaho members subject to their specific benefit plans.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-28Etelcalcetide (Parsabiv) for Secondary HyperparathyroidismThis policy governs medical necessity and prior authorization for etelcalcetide used to treat secondary hyperparathyroidism in adults with chronic kidney disease receiving hemodialysis. Coverage requires specified clinical, laboratory, treatment, and renewal criteria and is subject to the member-specific benefit plan.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-28Orthognathic SurgeryMedical policy governing when orthognathic (jaw) surgery is considered medically necessary or not for Bluecross Idaho members; applies to coverage determinations and preauthorization for corrective jaw procedures for functional deficits and congenital deformities.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Gene Therapies for Treatment of Wounds in Dystrophic Epidermolysis BullosaDefines medical necessity and prior authorization criteria for beremagene geperpavec-svdt (Vyjuvek) and prademagene zamikeracel (Zevaskyn) for treatment of wounds in individuals with recessive dystrophic epidermolysis bullosa (RDEB). Affects providers prescribing or administering these therapies and members receiving them.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Krystexxa (pegloticase) for refractory chronic goutMedical necessity criteria, prior authorization guidance, and coverage stance for Krystexxa (pegloticase) in adults with refractory chronic gout for Bluecross Idaho members.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Medicare Advantage Part B Medical Drugs Step TherapyDefines preferred and non-preferred Part B medical drugs for Blue Cross of Idaho Medicare Advantage members and the step-therapy criteria that govern coverage and prior authorization decisions for these drugs.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-01Intravenous rituximab for non-oncologic indicationsDefines medical benefit coverage, criteria, and continuation rules for IV rituximab when used for non-oncologic conditions under Blue Cross of Idaho plans; affects providers requesting prior authorization for these indications.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-02-01Esketamine Nasal Spray for DepressionMedical-necessity and prior-authorization criteria for esketamine nasal spray in adults with treatment-resistant depression or major depressive disorder with acute suicidal ideation or behavior, including FDA-label-consistent use and Spravato REMS compliance.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Intravenous Tocilizumab (IV tocilizumab) coverageDefines medical-benefit coverage, clinical criteria, and prior-authorization expectations for intravenous tocilizumab (including Actemra and listed biosimilars) for specified indications; applies to Blue Cross of Idaho members subject to their member-specific benefit plan.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Intravenous Ustekinumab for Inflammatory Bowel DiseaseMedical-benefit coverage and prior authorization for intravenous ustekinumab induction in adults with moderately to severely active Crohn's disease or ulcerative colitis; subcutaneous ustekinumab is handled under the pharmacy benefit.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Intravenous infliximab (medical benefit)Defines medical necessity criteria, dosing, continuation, and prior-authorization limits for intravenous infliximab under Blue Cross of Idaho medical benefit plans; affects providers requesting IV infliximab for covered indications.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Orencia (abatacept) for Intravenous UseThis policy governs medical-benefit coverage and prior authorization for intravenous abatacept for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, and acute graft-versus-host disease prophylaxis; subcutaneous abatacept is handled under the pharmacy benefit.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Simponi Aria (golimumab) for Intravenous UseThis policy governs medical-benefit coverage and prior-authorization criteria for intravenous golimumab (Simponi Aria) for specified inflammatory indications; it affects providers administering IV golimumab and members whose benefit plans follow Blue Cross of Idaho policies.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)This policy governs medical necessity and prior authorization for intravenous or subcutaneous immunoglobulin therapy and Vyvgart Hytrulo for individuals with chronic inflammatory demyelinating polyneuropathy. Coverage depends on diagnosis, objective impairment, treatment response, documentation, and product-specific requirements.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-18Guidelines for Prior Authorization of Pharmacologic TherapiesDefines Blue Cross of Idaho requirements and criteria for prior authorization, formulary exceptions, and evaluation of on- and off-label pharmacologic therapies for members covered under BCI benefit plans.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2025-10-30Testosterone Replacement TherapiesDefines clinical background, formulations, regulatory context, and evidence review for testosterone replacement therapy in individuals with androgen deficiency and clinical symptoms of hypogonadism; intended for clinicians and prior authorization reviewers.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyEff. 2025-10-30Treatment PlansThis policy describes when Blue Cross of Idaho may require a written treatment plan for complex medical, mental health, or pharmaceutical services. Providers may need to submit the plan with a prior authorization or concurrent review request, and the plan is evaluated against the applicable service-specific medical criteria.All Bluecross Idaho updates
- Prior AuthClinical/Medical PolicyAlpha1-Proteinase InhibitorsThis policy governs coverage and prior authorization for Aralast NP, Glassia, Prolastin-C, and Zemaira in adults with alpha1-antitrypsin deficiency and clinically evident emphysema. Coverage requires an approved indication and satisfaction of the specified serum AAT and post-bronchodilation FEV1 criteria.All Bluecross Idaho updates
Tool Description
Search Bluecross Idahoprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.